| Financial Year |
March 31 2023 |
| Monetary Funds |
18,982,282,736.44 |
| Held-for-trading Financial Assets |
631,837,626.83 |
| Notes Receivable |
89,354,811.00 |
| Accounts Receivable |
279,353,657.53 |
| Advances to Suppliers |
743,018,442.95 |
| Other Receivables |
743,417,611.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
36,981,720.65 |
| Inventories |
796,497,868.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,156,249,206.12 |
| Total Current Assets |
54,035,109,571.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,687,098,401.44 |
| Investment Properties |
18,652,523.91 |
| Fixed Assetes |
133,384,270,619.13 |
| Under-construction Projects |
20,967,562,901.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,691,644,205.47 |
| R&D expenses |
27,305,452.28 |
| Goodwill |
195,617,385.72 |
| Long-Term Deferred and Prepaid Expenses |
32,159,308.04 |
| Deferred Income Tax Assets |
454,146,150.91 |
| Other Non-Current Assets |
4,009,748,708.58 |
| Sub-Total of Non-Current Assets |
173,606,812,975.49 |
| Total Assets |
227,641,922,546.88 |
| Short-Term Loans |
17,459,733,373.91 |
| Trading Financial liabilities |
29,031,246.15 |
| Notes Payable |
1,187,411,917.02 |
| Accounts Payable |
9,976,118,132.31 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
937,265,726.29 |
| Taxes Payable |
843,104,521.74 |
| Interest Payable |
-- |
| Dividend Payable |
652,850,058.34 |
| Other payables |
5,889,728,528.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,340,848,429.86 |
| Other Current Liabilities |
10,015,919,087.84 |
| Sub-Total of Current Liabilities |
67,059,960,834.37 |
| Long-term Loans |
65,366,199,151.03 |
| Bonds Payable |
10,911,785,425.48 |
| Long-Term Accounts Payable |
423,854,038.69 |
| Special Payable |
-- |
| Estimatied Liabilities |
90,000,263.27 |
| Deferred Income Tax Liabilities |
262,922,271.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
77,705,268,749.32 |
| Total Liabilities |
144,765,229,583.69 |
| Paid-In Capital(Or Share Stock) |
8,381,963,164.00 |
| Capital Surplus |
14,419,422,881.54 |
| Surplus Reserve |
2,822,760,757.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
40,946,280,153.60 |
| Minority Stockholder's Interest |
11,577,571,017.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
71,299,121,945.71 |
| Owner's Equity（Stockholder's Equity） |
82,876,692,963.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
227,641,922,546.88 |
